Outlook Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-24-074966 |
2024-06-26 07:25:08 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-24-071756 |
2024-06-14 16:10:50 |
PRE 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-24-011916 |
2024-02-08 06:59:42 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-24-007787 |
2024-01-29 17:00:29 |
PRE 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-23-022226 |
2023-02-15 08:13:31 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-23-007566 |
2023-01-27 16:38:15 |
PRE 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-22-008303 |
2022-01-27 16:33:21 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-21-026016 |
2021-02-22 08:55:08 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-21-019888 |
2021-02-10 16:53:24 |
PRE 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-20-096526 |
2020-08-18 16:15:20 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-20-021988 |
2020-02-14 17:00:59 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001104659-20-009855 |
2020-02-03 17:19:51 |
PRE 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001144204-19-037252 |
2019-08-01 17:05:47 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001144204-18-045240 |
2018-08-17 06:59:35 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001144204-18-042474 |
2018-08-07 17:01:10 |
PRE 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001571049-17-008053 |
2017-09-29 16:10:28 |
DEF 14A
|
| 1649989 |
OTLK |
Outlook Therapeutics, Inc. |
0001571049-17-007879 |
2017-09-14 17:23:06 |
PRE 14A
|
